Abu Dhabi flu campaign tops 350,000 vaccinations as UAE clinics prepare for 2026 season

Mshale carried a consumer item this week on the importance of the influenza vaccine at a medical centre in Abu Dhabi, a small reminder with a larger message for UAE operators: flu vaccination is now a recurring primary-care, pharmacy and payer workflow.

The highest-stakes readers are COOs, CFOs and pharmacy operators. COOs need staffing, cold-chain and claims processes ready before September. CFOs need to know whether vaccination is a margin service, a retention tool or an insurer-funded preventive benefit. Pharmacy operators need to confirm which licensed sites can vaccinate, which staff can administer injections, and which regulator governs each branch.

Dubai clinics should plan before September demand

Dubai should be the first planning market for multi-emirate groups because the Dubai Health Authority (DHA) publishes facility circulars through Sheryan and regulates private health facilities in the emirate. DHA’s circular portal lists a 2025 immunisation guideline update dated 20 October 2025, plus earlier seasonal influenza vaccine statistics and pricing circulars. Operators should check Sheryan before launching any 2026 campaign, since the active rule set is the source for pricing, reporting and advertising claims.

For patient-facing pricing, the market remains mixed. Public-sector or campaign pricing may differ from private clinic pricing, and plan benefits can change by network. Private Dubai providers advertise flu shots from around AED 50 at some hospitals to AED 100-350 in clinic settings, while home vaccination providers advertise higher prices when a nurse visit is included. A clinic should publish the exact patient-pay price only after confirming stock, bundling and payer billing rules.

• Timing: plan purchasing and rosters for September to March, the same campaign window used in Abu Dhabi’s 2025-2026 programme.
• Eligibility: confirm age, pregnancy, chronic disease and healthcare-worker categories against DHA guidance before using marketing copy.
• Claims: verify coverage through the patient’s insurer or TPA before administration, especially for employer groups.
• Operations: document cold-chain logs, consent, batch number, post-vaccine observation and adverse-event escalation.

Abu Dhabi has shown the scale of organised demand

The Abu Dhabi Public Health Centre (ADPHC), working with the Department of Health – Abu Dhabi (DOH), said on 19 January 2026 that more than 350,000 people had been vaccinated in the emirate’s 2025-2026 seasonal influenza campaign. The campaign ran from September 2025 to March 2026. ADPHC said uptake rose from 162,761 vaccinations in 2022-2023, an increase of more than 115%.

That number matters for private operators. Abu Dhabi’s campaign used majlis, malls, workplaces, embassies, worker accommodation sites and government entities. A private group that treats flu vaccination as a passive walk-in service will miss employer demand, school-family demand and chronic-disease cohorts. DOH-regulated providers should use the ADPHC campaign model as a capacity signal, then check DOH requirements for facility scope, professional licensing and vaccine reporting.

“We encourage families, parents, employers and community members to take the vaccine and help protect those around them.” — HE Dr Rashed Al Suwaidi, Director General, Abu Dhabi Public Health Centre

Insurers should read the same data as a utilisation warning. Daman, Thiqa administrators and Sukoon will apply plan-specific rules, network rules and pre-authorisation logic where relevant. Clinics should avoid telling patients that the shot is covered until the insurer confirms the member’s benefit. The practical script is simple: bring Emirates ID, insurance card or app details, and any chronic-disease documentation requested by the provider.

Northern emirates pharmacies need a regulator map

In Sharjah, Ajman, Umm Al Quwain, Ras Al Khaimah and Fujairah, operators should start with the Ministry of Health and Prevention (MOHAP) and Emirates Health Services (EHS) channels. EHS lists seasonal influenza vaccination at AED 50 in its preventive vaccination services directory, but private pharmacy and clinic prices can differ by emirate, stock and service model. MOHAP’s 2025-2026 influenza awareness material should be checked before pharmacies publish eligibility or risk-group claims.

The commercial opportunity is modest per dose but useful at population scale. A family-medicine clinic can use flu vaccination to bring chronic-disease patients back into recall systems. A pharmacy chain can use it to test appointment booking, nurse utilisation and employer outreach. An insurer can reduce avoidable GP visits and respiratory complication claims if coverage rules are clear before demand peaks.

Dubai providers should check DHA circulars and licensed service scope, Abu Dhabi providers should follow DOH and ADPHC campaign guidance, and northern emirates providers should verify MOHAP and EHS rules. Patients and procurement teams looking for licensed pharmacy providers should use the UAE Open Healthcare Directory before choosing a vaccination site.